ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year

May 31, 2013

Chemoprevention Clinical Trials To starts In 1982 If Greenwald, DRCCA Board Can Move Fast Enough

August 28, 1981

ORI Misconduct Findings Announced In Two Cases

July 12, 1996

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978